Earth Science Tech Adds Pharmacist & LP3 as Chief of Pharmacy, Furthering Efforts to Obtain License to Distribute Controlled Substances

DORAL, Florida, April 11, 2018 -- Earth Science Tech, Inc. (OTC: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields as well as on R&D for certain medical devices, is pleased to announce that Mr. Jad Nammour has joined ETST as the Company’s new Chief of Pharmacy.

Mr. Nammour brings with him more than 20 years of experience as a pharmacist, as well as a specialized certification in the preparation of magisterial formulas. This means Mr. Nammour is trained to develop master formulae, which are the templates for the mass production of non-sterile medicinal products.

Mr. Nammour immediately fills the final important technical gap in the ETST production and development teams. Having a certified pharmacist on staff is required by law in order to obtain a license to distribute controlled substances from the government. Mr. Nammour’s task will be to ensure that use of controlled substances and drugs is managed and handled correctly, in keeping with the regulatory environment. He will also oversee all of the storage and warehousing of any controlled substances by the company.

In addition, Mr. Nammour’s experience in retail pharmacy will allow him to help ETST in the development and marketing of the company’s nutraceutical patents and pharmacological products and medical devices.

“I am very excited to be taking on this new challenge,” Nammour states.. “The range of quality products that ETST is preparing to place on the market, and the extremely interesting new products that they are developing, ensure that this will be a very rewarding experience.”

Dr. Michel Aube, the Company’s CEO & CSO, states, “The addition of Jad Nammour to our team means that the management and development teams are now complete. We have all of the knowledge, experience and proficiency that we need to bring our products to the marketplace and become a licensed distributor of drugs and controlled substances in Canada, as announced earlier this year. The distribution license will allow us to get the specific permit needed to import and export cannabis plants and their derivatives. ETST has strong international development potential as a wholesale distributor of these substances, and a pharmacist of Mr Nammour’s quality was mandatory.”

About Earth Science Tech, Inc. (ETST)

Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more, please visit: www.EarthScienceTech.com

About Earth Science Pharmaceutical

Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (sexually transmitted infections and/or diseases). Earth Science Pharmaceutical CEO Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.EarthSciencePharmaceutical.com

About Cannabis Therapeutics

Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals, as well as other products & solutions. Cannabis Therapeutics’ mission it to help change the health care landscape by introducing its proprietary cannabis-cannabinoid-based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.CannabisThera.com

About KannaBidioiD

KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioid is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.KannaBidioiDInc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:
Dave Demarest 
305.546.7640 Office

Company Contact:
www.EarthScienceTech.com 
Nickolas S. Tabraue
President & Director
305.615.2118 Office